Xueshu Zhang

发表

Advances in dendritic cell-based vaccine of cancer.

J. Xiang, J. Gordon, Xueshu Zhang, 2002, Cancer biotherapy & radiopharmaceuticals.

Acquired pMHC I Complexes Greatly Enhance CD4+ Th Cell's Stimulatory Effect on CD8+ T Cell-Mediated Diabetes in Transgenic RIP-mOVA Mice

J. Xiang, Yufeng Xie, K. A. Ahmed, 2008, Cellular and Molecular Immunology.

Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet β-cell ovalbumin antigen leading to diabetes

J. Xiang, R. Chibbar, Yufeng Xie, 2008, Autoimmunity.

Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.

J. Xiang, Chao-ke Tang, T. Moyana, 2007, Cellular & molecular immunology.

CTL Responses + Stimulating Efficient Central Memory CD 8 T Cell-Mediated Immune Suppression and Regulatory + 25 + Vaccine Counteracting CD 4 T Cell + Novel Exosome-Targeted CD 4

J. Xiang, Xiaochu Wu, Yangdou Wei, 2007 .

Novel Exosome-Targeted CD4+ T Cell Vaccine Counteracting CD4+25+ Regulatory T Cell-Mediated Immune Suppression and Stimulating Efficient Central Memory CD8+ CTL Responses1

J. Xiang, Xiaochu Wu, Yangdou Wei, 2007, The Journal of Immunology.

DNA microarray analysis of the gene expression profiles of naïve versus activated tumor-specific T cells.

J. Xiang, J. Gordon, Hui Huang, 2002, Life sciences.

Optimal TLR9 signal converts tolerogenic CD4–8– DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses

J. Xiang, Jinying Yuan, M. A. Munegowda, 2010, Journal of leukocyte biology.

CD40 ligation converts TGF-beta-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones.

J. Xiang, R. Kedl, Xueshu Zhang, 2009, Biochemical and biophysical research communications.

Conversion of tolerogenic CD4-8- dendritic cells to immunogenic ones inducing efficient antitumor immunity.

J. Xiang, M. Quereshi, T. Moyana, 2006, Cancer biotherapy & radiopharmaceuticals.

Natural CD8⁺25⁺ regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma.

J. Xiang, Yufeng Xie, Wei Li, 2013, Biochemical and biophysical research communications.

Enhanced suppression of polyclonal CD8+25+ regulatory T cells via exosomal arming of antigen‐specific peptide/MHC complexes

J. Xiang, R. Chibbar, A. Freywald, 2017, Journal of leukocyte biology.

CD4−8− Dendritic Cells Prime CD4+ T Regulatory 1 Cells to Suppress Antitumor Immunity1

J. Xiang, J. Gordon, Jinying Yuan, 2005, The Journal of Immunology.

Vaccine of engineered tumor cells secreting stromal cell-derived factor-1 induces T-cell dependent antitumor responses.

J. Xiang, C. Zheng, L. Su, 2005, Cancer biotherapy & radiopharmaceuticals.

Tolerogenic CD4-8- Dendritic Cells and their Conversion into Immunogenic Ones via TLR9 Signaling

Xueshu Zhang, 2008 .

Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays.

J. Xiang, J. Gordon, Zhuang Chen, 2002, Biochemical and biophysical research communications.

Natural CD8⁺25⁺ regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma.

J. Xiang, Yufeng Xie, Wei Li, 2013, Biochemical and Biophysical Research Communications - BBRC.